Tag archive for ‘Teva Pharmaceutical Industries’
Albert Hecht On Monday, September 11th, 2017

New Teva CEO Kare Schultz Grants $20 Million in Cash, $13.5 Million in Securities

New Teva CEO Kare Schultz will earn an annual salary of $2 million and a performance-dependent bonus of 140% of the base salary – and up to a maximum of 200%. The Israeli Teva Pharmaceutical Industries has More...

Omri Cohen On Thursday, August 3rd, 2017

Drama in Teva: Cutting 7,000 Jobs in 45 Countries ; Share Price Plunges

Teva Pharmaceutical Industries announced today that it is cutting 7,000 jobs in 45 countries and will close 15 factories by the end of 2018, following the publication of the financial results of the company for More...

Shai Genish On Thursday, December 22nd, 2016

Israeli Drugmaker Teva Pays $519 Million Fine in US for Foreign Bribes

US Justice Department announced Thursday that Israeli Teva Pharmaceutical Industries will pay $519 million fine to settle charges concerning violations of the Foreign Corrupt Practices Act (FCPA). More...

Jewish Business News On Monday, September 19th, 2016

Teva’s Trial Results Finds Drug Could Slow Huntington’s Disease

Teva Pharmaceutical Industries Ltd. today announced top-line results from an exploratory dose-ranging Phase 2 clinical trial, which could be a major breakthrough in the treatment of Huntigton’s Disease More...

Teva Completes Acquisition of Allergan’s Generics Business – Actavis Generics

  Teva Pharmaceutical Industries Ltd. and Allergan plc today announced that Teva has completed its acquisition of Allergan’s generics business – Actavis Generics. Allergan received $33.43 billion in More...

Teva Buys Allergan Distributor Anda for $500 Million

  One day after Teva Pharmaceutical Industries closed its deal to buy Allergan’s generics business for $33.43 billion in cash and $5.3 billion in shares, the company purchase Allergan’s 4th largest More...

Teva Sells $15 Billion of Bonds

  Teva Pharmaceutical Industries Ltd. announced today that it sold $15 billion bond offering, Monday to help fund its acquisition of Allergan PLC’s generics division. This makes Teva the latest company More...

Ilan Shavit On Thursday, February 18th, 2016

Teva Offering Concessions for Allergan Takeover – Bloomberg

  Teva Pharmaceutical Industries Ltd. will try to win fast European Union approval for its takeover of Allergan’s generics unit by making concessions to regulators, according to “Bloomberg” More...

AAI Letter to the FTC: Generic Pharmaceutical Merger TEVA and ALLERGAN Will Eliminate Important Competition

In a letter to the Federal Trade Commission (FTC), The American Antitrust Institute (AAI), a non-profit organization, outlined the competitive concerns raised by the proposed merger of generic pharmaceutical More...

Teva Raises Extra $658 Million in Underwriters’ Options

The underwriters for Teva Pharmaceutical Industries’ share offering last month have exercised their over-allotment option to purchase additional shares worth $658 million. Following the exercising of these More...

Email:

Delivered by FeedBurner